Clinical Use of Proteasome Inhibitors in the Treatment of Multiple Myeloma

Multiple myeloma (MM) is an incurable hematological malignancy characterized by the clonal proliferation of neoplastic plasma cells. The use of proteasome inhibitors in the treatment of MM has led to significant improvements in outcomes. This article reviews data on the use of the two approved prote...

Descripción completa

Detalles Bibliográficos
Autores principales: Merin, Noah M., Kelly, Kevin R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381198/
https://www.ncbi.nlm.nih.gov/pubmed/25545164
http://dx.doi.org/10.3390/ph8010001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381198/
https://www.ncbi.nlm.nih.gov/pubmed/25545164
http://dx.doi.org/10.3390/ph8010001

Ejemplares similares